Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(14%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
5
71%
Ph phase_3
2
29%

Phase Distribution

0

Early Stage

5

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
5(71.4%)
Phase 3Large-scale testing
2(28.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(2)
Completed(1)
Other(4)

Detailed Status

unknown3
Suspended1
Completed1
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 25 (71.4%)
Phase 32 (28.6%)

Trials by Status

suspended114%
completed114%
not_yet_recruiting114%
recruiting114%
unknown343%

Recent Activity

1 active trials
Showing 5 of 7
not_yet_recruitingphase_3

Efficacy and Safety of Utidelone Capsule and Utidelone Injection in Patients With HER-2 Negative Advanced Breast Cancer

NCT07684456
recruitingphase_2

Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer

NCT05398861
unknownphase_2

Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Solid Tumors

NCT04911907
unknownphase_3

Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NCT05673590
unknownphase_2

Utidelone Treated for the Recurrent or Metastatic Urothelial Carcinoma

NCT05895864
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT07684456Phase 3

Efficacy and Safety of Utidelone Capsule and Utidelone Injection in Patients With HER-2 Negative Advanced Breast Cancer

Not Yet Recruiting
NCT05398861Phase 2

Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer

Recruiting
NCT04911907Phase 2

Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Solid Tumors

Unknown
NCT05673590Phase 3

Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Unknown
NCT05895864Phase 2

Utidelone Treated for the Recurrent or Metastatic Urothelial Carcinoma

Unknown
NCT03693547Phase 2

Clinical Study of Utidelone Injection in Patients With Advanced Non-small Cell Lung Cancer（NSCLC）

Completed
NCT03906565Phase 2

Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Colorectal Cancer

Suspended

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7